Peter K Vadiveloo
Impact in
-
- Immune Response and Inflammation
- Immune cells in cancer
- Immune Cell Function and Interaction
- interferon and immune responses
-
- Asthma and respiratory diseases
Papers in
-
- NF-κB Signaling Pathways 2
-
- Immune cells in cancer 4
- Immune Response and Inflammation 3
- Co-authors
- John A. Hamilton (6 shared papers)Alastair G. Stewart (5 shared papers)Darren Charles Fernandes (3 shared papers)Trudi Harris (3 shared papers)Elizabeth Guida (3 shared papers)John W. Wilson (3 shared papers)Heather Stanton (2 shared papers)Noel Fidge (3 shared papers)
In The Last Decade
Peter K Vadiveloo
15 papers receiving 472 citations
Peers
Comparison fields: 5 of 75
- Immunology 161
- Physiology 122
- Cancer Research 66
- Immunology and Allergy 24
- Oncology 80
Countries citing papers authored by Peter K Vadiveloo
This map shows the geographic impact of Peter K Vadiveloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter K Vadiveloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter K Vadiveloo more than expected).
Fields of papers citing papers by Peter K Vadiveloo
This network shows the impact of papers produced by Peter K Vadiveloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter K Vadiveloo. The network helps show where Peter K Vadiveloo may publish in the future.
Co-authors
The 21 scholars most cited alongside Peter K Vadiveloo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 125 | |
| 2 | 1999 | 58 | |
| 3 | 2000 | 53 | |
| 4 | 1997 | 50 | |
| 5 | 1999 | 36 | |
| 6 | Interleukin-4 inhibits human smooth muscle cell proliferation. | 1994 | 35 |
| 7 | 2001 | 34 | |
| 8 | 1998 | 20 | |
| 9 | 1990 | 19 | |
| 10 | 2004 | 14 | |
| 11 | 1992 | 13 | |
| 12 | 1998 | 13 | |
| 13 | 1993 | 13 | |
| 14 | 2000 | 11 | |
| 15 | 1999 | 2 |
About Peter K Vadiveloo
Peter K Vadiveloo is a scholar working on Cancer Research, Immunology, Oncology, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 15 papers that have together received 496 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Immune cells in cancer (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Immune Response and Inflammation (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Cholesterol and Lipid Metabolism (2 papers), NF-κB Signaling Pathways (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Immunology (161 citations), Physiology (122 citations), Cancer Research (66 citations), Immunology and Allergy (24 citations) and Oncology (80 citations). Peter K Vadiveloo has collaborated with scholars based in Australia and Japan. Frequent co-authors include John A. Hamilton, Alastair G. Stewart, Darren Charles Fernandes, Trudi Harris, Elizabeth Guida, John W. Wilson, Heather Stanton, Noel Fidge, Gino Vairo and Enrico L Filonzi. Their work appears in journals such as Molecular Pharmacology, Cytokine, Journal of Interferon & Cytokine Research, Angiogenesis and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.